π£ VC round data is live. Check it out!
- Public Comps
- CurveBeam AI
CurveBeam AI Valuation Multiples
Discover revenue and EBITDA valuation multiples for CurveBeam AI and similar public comparables like EBM Technologies, Diagnos, MRSO, SenzaGen and more.
CurveBeam AI Overview
About CurveBeam AI
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the companyβs CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Founded
2009
HQ

Employees
50
Website
Financials (LTM)
EV
$30M
Valuation Multiples
Start free trialCurveBeam AI Financials
CurveBeam AI reported last 12-month revenue of $8M and negative EBITDA of ($7M).
In the same LTM period, CurveBeam AI generated $4M in gross profit, ($7M) in EBITDA losses, and had net loss of ($11M).
Revenue (LTM)
CurveBeam AI P&L
In the most recent fiscal year, CurveBeam AI reported revenue of $9M and EBITDA of ($7M).
CurveBeam AI is unprofitable as of last fiscal year, with gross margin of 45%, EBITDA margin of (83%), and net margin of (126%).
Financial data powered by Morningstar, Inc.
CurveBeam AI Stock Performance
CurveBeam AI has current market cap of $21M, and enterprise value of $30M.
Market Cap Evolution
CurveBeam AI's stock price is $0.04.
CurveBeam AI share price decreased by 2.3% in the last 30 days, and by 37.0% in the last year.
CurveBeam AI has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30M | $21M | -0.1% | -2.3% | -12.7% | -37.0% | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCurveBeam AI Valuation Multiples
CurveBeam AI trades at 3.8x EV/Revenue multiple, and (4.2x) EV/EBITDA.
EV / Revenue (LTM)
CurveBeam AI Financial Valuation Multiples
As of May 4, 2026, CurveBeam AI has market cap of $21M and EV of $30M.
CurveBeam AI has a P/E ratio of (1.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CurveBeam AI Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


CurveBeam AI Margins & Growth Rates
In the most recent fiscal year, CurveBeam AI reported gross margin of 45%, EBITDA margin of (83%), and net margin of (126%).
CurveBeam AI Margins
CurveBeam AI Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
CurveBeam AI Operational KPIs
CurveBeam AI's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
CurveBeam AI Competitors
CurveBeam AI competitors include EBM Technologies, Diagnos, MRSO, SenzaGen, NanoRepro, Cambridge Cognition, Biosynex, CareView Communications, NextPlat and Welby.
Most CurveBeam AI public comparables operate across Medical Imaging & Diagnostics, Healthcare Software, HealthTech, B2B SaaS and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.3x | β | 20.3x | β | |||
| 249.7x | β | (7.3x) | β | |||
| 1.3x | 1.3x | (47.2x) | β | |||
| 2.9x | β | (20.2x) | β | |||
| 2.5x | 0.7x | (3.5x) | (9.4x) | |||
| 1.7x | 1.6x | (32.9x) | 299.4x | |||
| 0.7x | β | (3537.5x) | β | |||
| 4.9x | β | 246.0x | β | |||
This data is available for Pro users. Sign up to see all CurveBeam AI competitors and their valuation data. Start Free Trial | ||||||
CurveBeam AI Funding History
Before going public, CurveBeam AI raised $25M in total equity funding, across 1 round.
CurveBeam AI Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CurveBeam AI
| When was CurveBeam AI founded? | CurveBeam AI was founded in 2009. |
| Where is CurveBeam AI headquartered? | CurveBeam AI is headquartered in Australia. |
| How many employees does CurveBeam AI have? | As of today, CurveBeam AI has over 50 employees. |
| Is CurveBeam AI publicly listed? | Yes, CurveBeam AI is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of CurveBeam AI? | CurveBeam AI trades under CVB ticker. |
| When did CurveBeam AI go public? | CurveBeam AI went public in 2023. |
| Who are competitors of CurveBeam AI? | CurveBeam AI main competitors include EBM Technologies, Diagnos, MRSO, SenzaGen, NanoRepro, Cambridge Cognition, Biosynex, CareView Communications, NextPlat, Welby. |
| What is the current market cap of CurveBeam AI? | CurveBeam AI's current market cap is $21M. |
| What is the current revenue of CurveBeam AI? | CurveBeam AI's last 12 months revenue is $8M. |
| What is the current EV/Revenue multiple of CurveBeam AI? | Current revenue multiple of CurveBeam AI is 3.8x. |
| Is CurveBeam AI profitable? | No, CurveBeam AI is not profitable. |
| What is the current EBITDA of CurveBeam AI? | CurveBeam AI has negative EBITDA and is not profitable. |
| What is CurveBeam AI's EBITDA margin? | CurveBeam AI's last 12 months EBITDA margin is (92%). |
| What is the current EV/EBITDA multiple of CurveBeam AI? | Current EBITDA multiple of CurveBeam AI is (4.2x). |
| What is the current FCF of CurveBeam AI? | CurveBeam AI's last 12 months FCF is ($7M). |
| What is CurveBeam AI's FCF margin? | CurveBeam AI's last 12 months FCF margin is (93%). |
| What is the current EV/FCF multiple of CurveBeam AI? | Current FCF multiple of CurveBeam AI is (4.1x). |
| How many companies CurveBeam AI has acquired to date? | CurveBeam AI hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies CurveBeam AI has invested to date? | CurveBeam AI hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to CurveBeam AI
Lists including CurveBeam AI
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.